Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine the optimal dose and imaging time
point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used in
future trials.